Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma

被引:0
|
作者
Wang, LS
Lin, HY
Chang, CJ
Fahn, HJ
Huang, MH
Lin, CFJ
机构
[1] Vet Gen Hosp, Dept Surg, Natl Yang Ming Med Coll, Div Thorac Surg, Taipei 11217, Taiwan
[2] Natl Yang Ming Med Univ, Taipei, Taiwan
[3] Vet Gen Hosp, Dept Allergy Immunol & Rheumatol, Taipei, Taiwan
[4] Vet Gen Hosp, Dept Biostat, Taipei, Taiwan
关键词
esophageal carcinoma; esophagectomy; nutrition and immune status;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: En bloc esophagectomy has been established as the treatment of choice for patients with resectable esophageal carcinoma. However, an extensive surgical procedure may result in further impairment of the patient's nutritional status and immune system. Thus a prospective study was undertaken to evaluate the perioperative sequential changes in patients' nutritional and immune status and the timing to institute postoperative adjuvant therapy. Methods: Thirty-seven patients (34 male, 3 female) who had undergone en bloc esophagectomy with gastric institution for epidermoid carcinoma of the esophagus were studied. The mean age was 62.3 years. The nutritional and immune assessments were performed preoperatively, on the third postoperative day, in the first week, second week, third week, and at the end of the first and third month. The biochemical studies for nutritional evaluation included serum albumin, cholesterol, iron, transferrin, magnesium, zinc, total iron binding capacity (TIBC), and nitrogen balance. Evaluation of the immune status consisted of: (1) total lymphocyte count, (2) lymphocyte subpopulation, (3) immunoglobulins, (4) complements (C3 and C4), (5) lymphocyte blastogenic responses, (6) tumor necrosis factor-alpha and interleukin-2 secretion activity from mononuclear cells, and (7) C-reactive protein (CRP) level. Results: All the parameters in nutritional assessment declined profoundly by the third postoperative day (P < 0.05). The most severe deterioration was in serum iron, followed by transferrin, TIBC, cholesterol, and zinc. Most of them returned to the preoperative levels within 2-3 weeks after surgery. However, the serum levels of iron, transferrin, and TIBC required a longer period of time (>1 month) to return to normal. A remarkable increase of serum CRP was detected in the first postoperative week (P < 0.05), but immunoglobulins and complements decreased significantly yet variably (P < 0.05) in the second or third postoperative week before gradually returning to preoperative levels. Moreover, during the first week after surgery, CD3 and CD8 diminished following esophageal surgery, whereas CD20, CD4/CD8 ratio, and lymphocyte blastogenic responses increased significantly (P < 0.05). Conclusions: Except for iron-related parameters, all the other nutritional parameters returned to the preoperative level by the third postoperative week. An adequate supplementation of iron and protein for 1-3 months after surgery is needed. En bloc esophagectomy might have only a mild and temporarily adverse effect on the host immune defense. Regarding the postoperative recovery of a patient's nutritional and immune status, post operative chemo-radiotherapy is optimally instituted after the third postoperative week, instead of within 2 weeks of surgery. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:90 / 98
页数:9
相关论文
共 50 条
  • [1] Should en bloc esophagectomy be the standard of care for esophageal carcinoma?
    Altorki, N
    Skinner, D
    ANNALS OF SURGERY, 2001, 234 (05) : 581 - 587
  • [2] EN-BLOC ESOPHAGECTOMY IN ESOPHAGEAL CANCER
    SIEWERT, JR
    HOLSCHER, AH
    RODER, J
    BARTELS, H
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1988, 373 (06): : 367 - 376
  • [3] En-bloc esophagectomy for esophageal cancer
    Tachibana, M
    Kinugasa, S
    Yoshimura, H
    Shibakita, M
    Tonomoto, Y
    Dhar, DK
    Tabara, H
    Nagasue, N
    AMERICAN JOURNAL OF SURGERY, 2004, 188 (03): : 254 - 260
  • [4] Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy
    Nigro, JJ
    DeMeester, SR
    Hagen, JA
    DeMeester, TR
    Peters, JH
    Kiyabu, M
    Campos, GMR
    Öberg, S
    Gastal, O
    Crookes, PF
    Bremner, CG
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (05): : 960 - 966
  • [5] Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy - Discussion
    Little, AG
    Wood, DE
    Benfield, JR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (05): : 966 - 968
  • [6] Outcomes of the Modified Thoracoscopic En-bloc Esophagectomy in Patients with Esophageal Cancer
    Long, Zhiqiang
    Liu, Qinghao
    Li, Jian
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (09)
  • [7] ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma
    Dae Joon Kim
    Ha Eun Kim
    Annals of Surgical Oncology, 2022, 29 : 4918 - 4919
  • [8] ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma
    Kim, Dae Joon
    Kim, Ha Eun
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 4918 - 4919
  • [9] Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma
    Schwameis, Katrin
    Green, Kyle M.
    Worrell, Stephanie G.
    Samaan, Jamil
    Cooper, Shannon
    Tatishchev, Sergei
    Oh, Daniel S.
    Hagen, Jeffrey A.
    DeMeester, Steven R.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3921 - 3925
  • [10] Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma
    Katrin Schwameis
    Kyle M. Green
    Stephanie G. Worrell
    Jamil Samaan
    Shannon Cooper
    Sergei Tatishchev
    Daniel S. Oh
    Jeffrey A. Hagen
    Steven R. DeMeester
    Annals of Surgical Oncology, 2017, 24 : 3921 - 3925